Rep. Dwight Evans discloses stock sales lagging S&P 500 on 30-day basis

Summary

The clip from BlindTrust presents Rep. Dwight Evans, D-PA, as having sold nine stocks with all underperforming the market on a forward basis. It highlights a May 7 sale of Thermo Fisher Scientific and notes his assignment to the Health subcommittee. The tone is mocking, with a repetitive chant-like close.

BlindTrust derives its scores from periodic transaction reports filed under the STOCK Act. It compares each trade's 30-day performance to the S&P 500 and flags committee overlaps. The segment draws on eight prior scored trades with a mean alpha of -5.7%.

Editorial Assessment

The underlying data from public disclosures holds up and is accurately summarized. Viewers miss the small dollar amounts involved ($1K-$15K brackets), the limited sample of eight trades, and the site's own acknowledgment that markets are difficult to time. The video emphasizes the Thermo Fisher committee overlap while omitting that no vote-trade linkage is claimed. Framing treats consistent underperformance as noteworthy without discussing how often random selling might produce similar results. Overall the piece is data-driven but selective in emphasis.